12:00 AM
Feb 10, 2003
 |  BioCentury  |  Politics, Policy & Law

Fattening up drug rebates

The Center for Medicaid and Medicare Services buried a bold statement on Medicaid savings in the fine print of the Bush administration's budget proposal that was submitted to Congress last week. CMS said it planned to implement "an improved and strengthened Medicaid drug rebate that will save the Federal government about $13.2 billion over the next ten years and save States a similar amount."

The $26.4 billion in savings presumably would come out of the profits of biopharmaceutical manufacturers, which pay rebates on drugs sold to Medicaid. Given the magnitude and specificity of the claim, it would be reasonable to assume that CMS has...

Read the full 502 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >